Monthly Archives: October 2012

The Energetics of Fear and Greed in the Boardroom
October 25, 2012

Like many things driven by human nature, venture-backed biotech boardrooms often swing between the emotions of fear and greed.  Fear of losing your shirt, or the greed of demanding more of the story than is warranted.  It’s the age-old imbalance

3 Comments

Biotech IPOs Are Back! Maybe.
October 16, 2012

Two recent offerings, Kythera and Intercept, both ripped out of the gates with 20% rallies above their offer price last week.  A flood of new S1 filings is to be expected.  With all that inventory out there of emerging private

1 Comment

New Data on Venture Capital Returns: Exits Are Indeed Improving
October 3, 2012

Correlation Ventures, a new analytics-driven venture firm, just came out with some interesting data on US venture capital returns over the past decade. Instead of taking a “birth” vintage approach to returns, which is the way venture fund vintages and

1 Comment